Corcept Therapeutics Inc

MetLife Investment Management, LLC CORT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

6,070

Value ($000)

211

Weight

0.0%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	211	0.0%	6,070	12/31/2025
2025 Q3	11/13/2025	500	0.0%	6,017	9/30/2025
2025 Q2	8/13/2025	429	0.0%	5,843	6/30/2025
2025 Q1	5/14/2025	5,410	0.0%	47,363	3/31/2025
2024 Q4	2/13/2025	2,461	0.0%	48,844	12/31/2024
2024 Q3	11/13/2024	2,159	0.0%	46,658	9/30/2024
2024 Q2	8/13/2024	1,522	0.0%	46,838	6/30/2024
2024 Q1	5/14/2024	1,066	0.0%	42,323	3/31/2024
2023 Q4	4/22/2024	1,375	0.0%	42,323	12/31/2023
2023 Q3	5/9/2024	1,153	0.0%	42,323	9/30/2023
2023 Q2	4/29/2024	942	0.0%	42,323	6/30/2023
2023 Q1	5/9/2024	1,020	0.0%	47,099	3/31/2023
2022 Q4	5/10/2024	957	0.0%	47,099	12/31/2022
2022 Q3	5/10/2024	1,208	0.0%	47,099	9/30/2022
2022 Q2	5/10/2024	1,120	0.0%	47,099	6/30/2022
2022 Q1	5/10/2024	1,061	0.0%	47,099	3/31/2022
2021 Q4	5/17/2024	670	0.0%	33,849	12/31/2021
2021 Q3	5/17/2024	666	0.0%	33,849	9/30/2021
2021 Q2	5/17/2024	866	0.0%	39,384	6/30/2021
2021 Q1	5/17/2024	937	0.0%	39,384	3/31/2021
2020 Q4	5/24/2024	1,030	0.0%	39,384	12/31/2020
2020 Q3	5/24/2024	756	0.0%	43,446	9/30/2020
2020 Q2	5/24/2024	731	0.0%	43,446	6/30/2020
2020 Q1	7/12/2023	517	0.0%	43,446	3/31/2020
2019 Q4	7/12/2023	526	0.0%	43,446	12/31/2019
2019 Q3	7/12/2023	614	0.0%	43,446	9/30/2019
2019 Q2	7/12/2023	484	0.0%	43,446	6/30/2019
2019 Q1	7/13/2023	510	0.0%	43,446	3/31/2019
2018 Q4	7/13/2023	580	0.0%	43,446	12/31/2018
2018 Q3	7/13/2023	609	0.0%	43,446	9/30/2018